Autopsy report · NCT03753282

Outcome After Avascular Necrosis of the Femoral Head in Young Patients

“difficulty enrolling patients, no patient recruited”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

University Hospital, Basel, Switzerland

Sponsor type

University, hospital or other

Conditions

Avascular Necrosis of the Femoral Head

Interventions

questionnaires for patient reported outcome; questionnaire for course of the disease

Participants

0

Trials that died the same way

• Non-Contrast Magnetic Resonance Angiography Assessment of Patients Referred for Transcatheter Aortic Valve Implantation
  “Difficulty enrolling patients” (89% match in meaning)
• Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer
  “Difficulty in enrolling patients” (88% match in meaning)
• Microcirculation in Cardiac Surgery
  “Difficulty in enrolling new patients” (85% match in meaning)
• The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus
  “Unable to enroll patients” (85% match in meaning)
• Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement
  “Unable to enroll appropriate patients” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.